Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Summary for Patients
space
 arrow  Summary for Patients (PDF)
space
 arrow  Figures/Tables List
space
 arrow  Related ACP Content
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Selvin, E.
space
  arrow  Golden, S. H.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ARTICLE

Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus

right arrow Elizabeth Selvin, MPH; Spyridon Marinopoulos, MD, MBA; Gail Berkenblit, MD, PhD; Tejal Rami, MPH; Frederick L. Brancati, MD, MHS; Neil R. Powe, MD, MPH, MBA; and Sherita Hill Golden, MD, MHS

21 September 2004 | Volume 141 Issue 6 | Pages 421-431

Background: In persons with diabetes, chronic hyperglycemia (assessed by glycosylated hemoglobin level) is related to the development of microvascular disease; however, the relation of glycosylated hemoglobin to macrovascular disease is less clear.

Purpose: To conduct a meta-analysis of observational studies of the association between glycosylated hemoglobin and cardiovascular disease in diabetic persons.

Data Sources: Search of the MEDLINE database by using Medical Subject Heading search terms and key words related to glycosylated hemoglobin, diabetes, and cardiovascular disease.

Study Selection: Prospective cohort studies with data on glycosylated hemoglobin levels and incident cardiovascular disease.

Data Extraction: Relative risk estimates were derived or abstracted from each cohort study that met the inclusion criteria.

Data Synthesis: Adjusted relative risk estimates for glycosylated hemoglobin (total glycosylated hemoglobin, hemoglobin A1, or hemoglobin A1c levels) and cardiovascular disease events (coronary heart disease and stroke) were pooled by using random-effects models. Three studies involved persons with type 1 diabetes (n = 1688), and 10 studies involved persons with type 2 diabetes (n = 7435). The pooled relative risk for cardiovascular disease was 1.18; this represented a 1–percentage point increase in glycosylated hemoglobin level (95% CI, 1.10 to 1.26) in persons with type 2 diabetes. Results in persons with type 1 diabetes were similar but had a wider CI (pooled relative risk, 1.15 [CI, 0.92 to 1.43]).

Limitations: This review largely reflects the limitations of the literature. Important concerns were residual confounding, the possibility of publication bias, the small number of studies, and the heterogeneity of study results.

Conclusions: Pending confirmation from large, ongoing clinical trials, this analysis shows that observational studies are consistent with limited clinical trial data and suggests that chronic hyperglycemia is associated with an increased risk for cardiovascular disease in persons with diabetes.


Editors' Notes
space

Context

  • The relationship between glycosylated hemoglobin and cardiovascular disease in diabetic persons is less clear than its relationship with microvascular disease.

Contribution

  • This meta-analysis of 13 observational studies estimates that, for every 1-percentage point increase in glycosylated hemoglobin, the relative risk for any cardiovascular disease event is 1.18 for patients with type 2 diabetes mellitus and 1.15 for patients with type 1 diabetes mellitus.

Cautions

  • Although this analysis suggests that improvements in glycosylated hemoglobin level might translate into reductions in cardiovascular events, confirmation from randomized trials is necessary.

–The Editors

 

Author and Article Information
space

From Johns Hopkins University Bloomberg School of Public Health and Johns Hopkins University School of Medicine, Baltimore, Maryland.

Grant Support: By the Agency for Healthcare Research and Quality (contract no. 290-97-0006). Ms. Selvin was supported by a grant from the National Heart, Lung, and Blood Institute (grant no. T32HL07024). Dr. Golden was supported by a grant from the Robert Wood Johnson Foundation Minority Medical Faculty Development Program. Dr. Brancati was supported by a Mid-Career Award for Patient-Oriented Research from the National Institutes of Health (contract no. K24-DK6222-O1). Dr. Powe was supported in part by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (grant no. K24DK02643).

Potential Financial Conflicts of Interest: None disclosed.

Requests for Single Reprints: Sherita Hill Golden, MD, MHS, Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, 2024 East Monument Street, Suite 2-616, Baltimore, MD 21205; e-mail, sgolden1{at}jhem.jhmi.edu.

Current Author Addresses: Ms. Selvin, Ms. Rami, and Drs. Brancati, Powe, and Golden: Johns Hopkins University, Welch Center for Prevention, Epidemiology and Clinical Research, 2024 East Monument Street, Suite 2-600, Baltimore, MD 21205.

Dr. Marinopoulos: Johns Hopkins University, 10753 Falls Road, Suite 325, Lutherville, MD 21093.

Dr. Berkenblit: Johns Hopkins Outpatient Center, 601 North Caroline Street, Suite 7143, Baltimore, MD 21287.

Author Contributions: Conception and design: E. Selvin, S. Marinopoulos, T. Rami, F.L. Brancati, N.R. Powe, S.H. Golden.

Analysis and interpretation of the data: E. Selvin, S. Marinopoulos, G. Berkenblit, T. Rami, F.L. Brancati, N.R. Powe, S.H. Golden.

Drafting of the article: E. Selvin, S.H. Golden.

Critical revision of the article for important intellectual content: E. Selvin, S. Marinopoulos, G. Berkenblit, F.L. Brancati, N.R. Powe, S.H. Golden.

Final approval of the article: E. Selvin, S. Marinopoulos, G. Berkenblit, T. Rami, F.L. Brancati, N.R. Powe, S.H. Golden.

Statistical expertise: E. Selvin.

Obtaining of funding: F.L. Brancati, N.R. Powe, S.H. Golden.

Administrative, technical, or logistic support: T. Rami, N.R. Powe.

Collection and assembly of data: E. Selvin, S. Marinopoulos, G. Berkenblit, T. Rami, S.H. Golden.


Related articles in Annals:

Articles
Association of Hemoglobin A1c with Cardiovascular Disease and Mortality in Adults: The European Prospective Investigation into Cancer in Norfolk
Kay-Tee Khaw, Nicholas Wareham, Sheila Bingham, Robert Luben, Ailsa Welch, AND Nicholas Day
Annals 2004 141: 413-420. [ABSTRACT][SUMMARY][Full Text]  

Editorials
Glycosylated Hemoglobin: Finally Ready for Prime Time as a Cardiovascular Risk Factor
Hertzel C. Gerstein
Annals 2004 141: 475-476. [Full Text]  

Summaries for Patients
The Relationship between Blood Sugar Control and Cardiovascular Disease in Patients with Diabetes
Annals 2004 141: I-21. [Full Text]  



This article has been cited by other articles:


Home page
NEJMHome page
W. T. Cefalu
Glycemic Targets and Cardiovascular Disease
N. Engl. J. Med., June 12, 2008; 358(24): 2633 - 2635.
[Full Text] [PDF]


Home page
NEJMHome page
The Action to Control Cardiovascular Risk in Diabe
Effects of Intensive Glucose Lowering in Type 2 Diabetes
N. Engl. J. Med., June 12, 2008; 358(24): 2545 - 2559.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
The ADVANCE Collaborative Group
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
N. Engl. J. Med., June 12, 2008; 358(24): 2560 - 2572.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
R. K. Simmons, S. Sharp, S. M. Boekholdt, L. A. Sargeant, K.-T. Khaw, N. J. Wareham, and S. J. Griffin
Evaluation of the Framingham Risk Score in the European Prospective Investigation of Cancer-Norfolk Cohort: Does Adding Glycated Hemoglobin Improve the Prediction of Coronary Heart Disease Events?
Arch Intern Med, June 9, 2008; 168(11): 1209 - 1216.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
S. L. Norris, D. Kansagara, C. Bougatsos, and R. Fu
Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force
Ann Intern Med, June 3, 2008; 148(11): 855 - 868.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
Z. T. Bloomgarden
Cardiovascular Disease in Diabetes
Diabetes Care, June 1, 2008; 31(6): 1260 - 1266.
[Full Text] [PDF]


Home page
Diabetes CareHome page
N. Brewer, C. S. Wright, N. Travier, C. W. Cunningham, J. Hornell, N. Pearce, and M. Jeffreys
A New Zealand Linkage Study Examining the Associations Between A1C Concentration and Mortality
Diabetes Care, June 1, 2008; 31(6): 1144 - 1149.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
B. Boden-Albala, S. Cammack, J. Chong, C. Wang, C. Wright, T. Rundek, M. S.V. Elkind, M. C. Paik, and R. L. Sacco
Diabetes, Fasting Glucose Levels, and Risk of Ischemic Stroke and Vascular Events: Findings from the Northern Manhattan Study (NOMAS)
Diabetes Care, June 1, 2008; 31(6): 1132 - 1137.
[Abstract] [Full Text] [PDF]


Home page
The Diabetes EducatorHome page
R. K. Campbell and J. R. White Jr
More Choices Than Ever Before: Emerging Therapies for Type 2 Diabetes
The Diabetes Educator, May 1, 2008; 34(3): 518 - 534.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
A. C. Shirali and M. J. Bia
Management of Cardiovascular Disease in Renal Transplant Recipients
Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 491 - 504.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
Z. Milicevic, I. Raz, S. D. Beattie, B. N. Campaigne, S. Sarwat, E. Gromniak, I. Kowalska, E. Galic, M. Tan, and M. Hanefeld
Natural History of Cardiovascular Disease in Patients With Diabetes: Role of hyperglycemia
Diabetes Care, February 1, 2008; 31(Supplement_2): S155 - S160.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
C. Bianchi, R. Miccoli, G. Penno, and S. Del Prato
Primary Prevention of Cardiovascular Disease in People With Dysglycemia
Diabetes Care, February 1, 2008; 31(Supplement_2): S208 - S214.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
D. Giugliano, A. Ceriello, and K. Esposito
Glucose metabolism and hyperglycemia
Am. J. Clinical Nutrition, January 1, 2008; 87(1): 217S - 222S.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
N. M. Hadler
Oral Hypoglycemics and Diabetic Nephropathy
Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 159 - 162.
[Full Text] [PDF]


Home page
Diabetes CareHome page
American Diabetes Association
Standards of Medical Care in Diabetes--2008
Diabetes Care, January 1, 2008; 31(Supplement_1): S12 - S54.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R. J. Sigal, G. P. Kenny, N. G. Boule, G. A. Wells, D. Prud'homme, M. Fortier, R. D. Reid, H. Tulloch, D. Coyle, P. Phillips, et al.
Effects of Aerobic Training, Resistance Training, or Both on Glycemic Control in Type 2 Diabetes: A Randomized Trial
Ann Intern Med, September 18, 2007; 147(6): 357 - 369.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
W. E. Kraus and B. D. Levine
Exercise Training for Diabetes: The "Strength" of the Evidence
Ann Intern Med, September 18, 2007; 147(6): 423 - 424.
[Full Text] [PDF]


Home page
Clin. DiabetesHome page
G. D. Harris
A 52-Year-Old Woman With Hypertension and Diabetes Who Presents With Chest Pain
Clin. Diabetes, July 1, 2007; 25(3): 115 - 118.
[Full Text] [PDF]


Home page
Diabetes CareHome page
K. Krzyzanowska, F. Mittermayer, M. Wolzt, and G. Schernthaner
Asymmetric Dimethylarginine Predicts Cardiovascular Events in Patients With Type 2 Diabetes
Diabetes Care, July 1, 2007; 30(7): 1834 - 1839.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Eur. Heart J. Suppl., June 1, 2007; 9(suppl_C): C3 - C74.
[Full Text] [PDF]


Home page
Diabetes CareHome page
P. Berikai, P. M. Meyer, R. Kazlauskaite, B. Savoy, K. Kozik, and L. Fogelfeld
Gain in Patients' Knowledge of Diabetes Management Targets Is Associated With Better Glycemic Control
Diabetes Care, June 1, 2007; 30(6): 1587 - 1589.
[Full Text] [PDF]


Home page
Ann Fam MedHome page
M. L. Parchman, J. A. Pugh, R. L. Romero, and K. W. Bowers
Competing Demands or Clinical Inertia: The Case of Elevated Glycosylated Hemoglobin
Ann. Fam. Med, May 1, 2007; 5(3): 196 - 201.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Avogaro, C. Giorda, M. Maggini, E. Mannucci, R. Raschetti, F. Lombardo, S. Spila-Alegiani, S. Turco, M. Velussi, E. Ferrannini, et al.
Incidence of Coronary Heart Disease in Type 2 Diabetic Men and Women: Impact of microvascular complications, treatment, and geographic location
Diabetes Care, May 1, 2007; 30(5): 1241 - 1247.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
N. J. Snowling and W. G. Hopkins
Effects of Different Modes of Exercise Training on Glucose Control and Risk Factors for Complications in Type 2 Diabetic Patients: a Meta-Analysis: Response to Balducci et al.
Diabetes Care, April 1, 2007; 30(4): e26 - e26.
[Full Text] [PDF]


Home page
StrokeHome page
P. K. Myint, S. Sinha, N. J. Wareham, S. A. Bingham, R. N. Luben, A. A. Welch, and K.-T. Khaw
Glycated Hemoglobin and Risk of Stroke in People Without Known Diabetes in the European Prospective Investigation Into Cancer (EPIC)-Norfolk Prospective Population Study: A Threshold Relationship?
Stroke, February 1, 2007; 38(2): 271 - 275.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. B. Buse, H. N. Ginsberg, G. L. Bakris, N. G. Clark, F. Costa, R. Eckel, V. Fonseca, H. C. Gerstein, S. Grundy, R. W. Nesto, et al.
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A Scientific Statement From the American Heart Association and the American Diabetes Association
Circulation, January 2, 2007; 115(1): 114 - 126.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Eur. Heart J., January 1, 2007; 28(1): 88 - 136.
[Full Text] [PDF]


Home page
Diabetes CareHome page
J. B. Buse, H. N. Ginsberg, G. L. Bakris, N. G. Clark, F. Costa, R. Eckel, V. Fonseca, H. C. Gerstein, S. Grundy, R. W. Nesto, et al.
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A scientific statement from the American Heart Association and the American Diabetes Association
Diabetes Care, January 1, 2007; 30(1): 162 - 172.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
American Diabetes Association
Standards of Medical Care in Diabetes--2007
Diabetes Care, January 1, 2007; 30(suppl_1): S4 - S41.
[Full Text] [PDF]


Home page
Diabetes CareHome page
N. J. Snowling and W. G. Hopkins
Effects of Different Modes of Exercise Training on Glucose Control and Risk Factors for Complications in Type 2 Diabetic Patients: A meta-analysis.
Diabetes Care, November 1, 2006; 29(11): 2518 - 2527.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
P. M. Ho, J. S. Rumsfeld, F. A. Masoudi, D. L. McClure, M. E. Plomondon, J. F. Steiner, and D. J. Magid
Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus.
Arch Intern Med, September 25, 2006; 166(17): 1836 - 1841.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
C. Kummer, C. Laflamme, and J. Lam-mcculloch
26472 - IS HBA1C A MARKER FOR POOR OUTCOME AFTER CABG IN UNDIAGNOSED DIABETICS?
Can J Anesth, June 1, 2006; 53(suppl_1): 26472 - 26472.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
P. Muntner, K. B. DeSalvo, R. P. Wildman, P. Raggi, J. He, and P. K. Whelton
Trends in the Prevalence, Awareness, Treatment, and Control of Cardiovascular Disease Risk Factors among Noninstitutionalized Patients with a History of Myocardial Infarction and Stroke
Am. J. Epidemiol., May 15, 2006; 163(10): 913 - 920.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
Z. T. Bloomgarden
Cardiovascular Disease
Diabetes Care, May 1, 2006; 29(5): 1160 - 1166.
[Full Text] [PDF]


Home page
JAMAHome page
C. D. Saudek, R. L. Derr, and R. R. Kalyani
Assessing Glycemia in Diabetes Using Self-monitoring Blood Glucose and Hemoglobin A1c
JAMA, April 12, 2006; 295(14): 1688 - 1697.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. S. Soedamah-Muthu, J. H. Fuller, H. E. Mulnier, V. S. Raleigh, R. A. Lawrenson, and H. M. Colhoun
High Risk of Cardiovascular Disease in Patients With Type 1 Diabetes in the U.K.: A cohort study using the General Practice Research Database
Diabetes Care, April 1, 2006; 29(4): 798 - 804.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
E. Selvin, K. Wattanakit, M. W. Steffes, J. Coresh, and A. R. Sharrett
HbA1c and Peripheral Arterial Disease in Diabetes: The Atherosclerosis Risk in Communities study
Diabetes Care, April 1, 2006; 29(4): 877 - 882.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
J.R. Timmer, J.P. Ottervanger, H.J.G. Bilo, J.H.E. Dambrink, K. Miedema, J.C.A. Hoorntje, and F. Zijlstra
Prognostic value of admission glucose and glycosylated haemoglobin levels in acute coronary syndromes
QJM, April 1, 2006; 99(4): 237 - 243.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
A. S. Dronge, M. F. Perkal, S. Kancir, J. Concato, M. Aslan, and R. A. Rosenthal
Long-term Glycemic Control and Postoperative Infectious Complications
Arch Surg, April 1, 2006; 141(4): 375 - 380.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. P. Marso and W. R. Hiatt
Peripheral Arterial Disease in Patients With Diabetes
J. Am. Coll. Cardiol., March 7, 2006; 47(5): 921 - 929.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. Sander, C. Schulze-Horn, H. Bickel, H. Gnahn, E. Bartels, and B. Conrad
Combined Effects of Hemoglobin A1c and C-Reactive Protein on the Progression of Subclinical Carotid Atherosclerosis: The INVADE Study
Stroke, February 1, 2006; 37(2): 351 - 357.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
L. Kennedy, W. H. Herman, P. Strange, A. Harris, and for the GOAL A1C Team
Impact of Active Versus Usual Algorithmic Titration of Basal Insulin and Point-of-Care Versus Laboratory Measurement of HbA1c on Glycemic Control in Patients With Type 2 Diabetes: The Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial
Diabetes Care, January 1, 2006; 29(1): 1 - 8.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
American Diabetes Association
Standards of Medical Care in Diabetes-2006
Diabetes Care, January 1, 2006; 29(suppl_1): S4 - S42.
[Full Text] [PDF]


Home page
NEJMHome page
W. T. Cefalu
Glycemic Control and Cardiovascular Disease -- Should We Reassess Clinical Goals?
N. Engl. J. Med., December 22, 2005; 353(25): 2707 - 2709.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
L. Wartofsky
Update in Endocrinology
Ann Intern Med, November 1, 2005; 143(9): 673 - 682.
[Full Text] [PDF]


Home page
Diabetes CareHome page
D. T. Eurich, S. R. Majumdar, F. A. McAlister, R. T. Tsuyuki, and J. A. Johnson
Improved Clinical Outcomes Associated With Metformin in Patients With Diabetes and Heart Failure
Diabetes Care, October 1, 2005; 28(10): 2345 - 2351.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. Chodosh, S. C. Morton, W. Mojica, M. Maglione, M. J. Suttorp, L. Hilton, S. Rhodes, and P. Shekelle
Meta-Analysis: Chronic Disease Self-Management Programs for Older Adults
Ann Intern Med, September 20, 2005; 143(6): 427 - 438.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
E. Selvin, J. Coresh, S. H. Golden, F. L. Brancati, A. R. Folsom, and M. W. Steffes
Glycemic Control and Coronary Heart Disease Risk in Persons With and Without Diabetes: The Atherosclerosis Risk in Communities Study
Arch Intern Med, September 12, 2005; 165(16): 1910 - 1916.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
P. Muntner, R. P. Wildman, K. Reynolds, K. B. DeSalvo, J. Chen, and V. Fonseca
Relationship Between HbA1c Level and Peripheral Arterial Disease
Diabetes Care, August 1, 2005; 28(8): 1981 - 1987.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Med.Home page
Other articles noted
Evid. Based Med., June 1, 2005; 10(3): 95 - 96.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. C. Bunt, P. A. Tataranni, and A. D. Salbe
Intrauterine Exposure to Diabetes Is a Determinant of Hemoglobin A1c and Systolic Blood Pressure in Pima Indian Children
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3225 - 3229.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Med.Home page
R. J Sigal
Haemoglobin A1c concentrations were associated with increased cardiovascular disease and all cause mortality
Evid. Based Med., April 1, 2005; 10(2): 57 - 57.
[Full Text] [PDF]


Home page
Diabetes CareHome page
American Diabetes Association
Standards of Medical Care in Diabetes
Diabetes Care, January 1, 2005; 28(suppl_1): S4 - S36.
[Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
Elevated Blood Sugar: Apparent Cardiac Risk Factor
Journal Watch Cardiology, December 31, 2004; 2004(1231): 3 - 3.
[Full Text]


Home page
Journal Watch CardiologyHome page
Elevated Blood Sugar: Apparent Cardiac Risk Factor
Journal Watch Cardiology, November 5, 2004; 2004(1105): 1 - 1.
[Full Text]